National Guideline Clearinghouse | Imatinib mesylate in the adjuvant treatment of gastrointestinal stromal tumours (GIST).

Guideline Title
Cancer Care Ontario Web site [CCO]
Imatinib mesylate in the adjuvant treatment of gastrointestinal stromal tumours (GIST).

Bibliographic Source(s)
Asmis T, Haynes AE, Swallow C, Verma S. Imatinib mesylate in the adjuvant treatment of gastrointestinal stromal tumours (GIST). Toronto (ON): Cancer Care Ontario (CCO); 2010 May 31. 17 p. (Special advice report; no. 17). [8 references]

Guideline Status
This is the current release of the guideline.

The SPECIAL ADVICE REPORT over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site [CCO] for details on any new evidence that has emerged and implications to the guidelines.

full-text:
National Guideline Clearinghouse | Imatinib mesylate in the adjuvant treatment of gastrointestinal stromal tumours (GIST).